VAERS reports by lot

Sanofi Pasteur DTaP/Tdap lot U8383AB: VAERS reports

25 VAERS reports list lot U8383AB as a Sanofi Pasteur DTaP/Tdap vaccine, received between 2025-08-18 and 2026-03-31. Data: VAERS public files through 28 May 2026 (site extract 2026-10-28).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
25
Reports
0%
Marked serious
0
With a death outcome
8
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Injection-site / Local reaction2364%
Dermatological (non-injection-site)411%
Respiratory38%
Allergic / Anaphylactic26%
General / Systemic (non-local)26%
Musculoskeletal13%
Psychiatric / Neuropsychiatric13%

Where reports came from

U.S. state of the reporter, where given (top 12).

StateReports
Michigan6
California3
Massachusetts3
Oklahoma1
North Carolina1
Oregon1
Washington1
Idaho1
New York1
Missouri1
Arkansas1
Colorado1

Reports by month received

MonthReportsBar
2025-084
2025-096
2025-103
2025-113
2025-121
2026-013
2026-021
2026-034

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Nearby Sanofi Pasteur DTaP/Tdap lots (A–Z): U8122AA · U8209CB · U8232AA · UF456AA

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-10-28 18:08 UTC. Not medical advice. Report errors via contact.